Drug intelligence / Profile preview

apixaban + digoxin

Development stage
Unknown
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

**Apixaban + digoxin** is a combination of two active pharmaceutical ingredients: apixaban, an oral anticoagulant that is a direct and highly selective inhibitor of factor Xa, and digoxin, a cardiac glycoside that inhibits the Na+/K+ ATPase pump, increasing intracellular calcium and improving cardiac contractility. Apixaban is used in prevention and treatment of thromboembolic events (including stroke and deep vein thrombosis) in conditions such as nonvalvular atrial fibrillation, and after major orthopedic surgery. Digoxin is primarily used for heart failure and certain arrhythmias, such as atrial fibrillation. There is no significant pharmacokinetic interaction between apixaban and digoxin; both can be coadministered safely under appropriate medical supervision.

Brand names
Apo-Digoxin
Other names
apixaban + digoxinEliquis + digoxin
02

Targets

ATP1A (Sodium/potassium-transporting ATPase)F10 (Factor Xa)

Beyond the preview

Go deeper on apixaban + digoxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on apixaban + digoxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call